Health data is governed by laws nearly 25 years old, and as more types of health data are created, from fitness to biometric to genetic data, Washington can’t keep up.
Cost of innovation making fight against superbugs near impossible
Payers spoiled the debut of the first two PCSK9 drugs from Sanofi and Amgen. A third is poised for approval — but if history is any guide, its U.S. market-access path will be anything but smooth.
3 rare disease campaigns that conquered challenges around marketing these conditions
